These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24944373)

  • 1. Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.
    Kane RC
    Curr Ther Res Clin Exp; 2003 Apr; 64(4):263-8. PubMed ID: 24944373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
    Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
    Coyne DW; Adkinson NF; Nissenson AR; Fishbane S; Agarwal R; Eschbach JW; Michael B; Folkert V; Batlle D; Trout JR; Dahl N; Myirski P; Strobos J; Warnock DG;
    Kidney Int; 2003 Jan; 63(1):217-24. PubMed ID: 12472786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.
    Seligman PA; Dahl NV; Strobos J; Kimko HC; Schleicher RB; Jones M; Ducharme MP
    Pharmacotherapy; 2004 May; 24(5):574-83. PubMed ID: 15162891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
    Panesar A; Agarwal R
    Am J Kidney Dis; 2002 Nov; 40(5):924-31. PubMed ID: 12407636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety.
    Michael B; Coyne DW; Folkert VW; Dahl NV; Warnock DG;
    Nephrol Dial Transplant; 2004 Jun; 19(6):1576-80. PubMed ID: 15034152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
    Faich G; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure.
    Eche IM; Owen KL; Eche IJ; Patel P; Sabe M
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):365-370. PubMed ID: 33563034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis.
    Warady BA; Zobrist RH; Finan E;
    Pediatr Nephrol; 2006 Apr; 21(4):553-60. PubMed ID: 16520948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
    Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
    Warady BA; Zobrist RH; Wu J; Finan E;
    Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
    Charytan C; Schwenk MH; Al-Saloum MM; Spinowitz BS
    Nephron Clin Pract; 2004; 96(2):c63-6. PubMed ID: 14988600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency.
    Borreda I; Zukermann R; Epstein D; Marcusohn E
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484211055639. PubMed ID: 34994220
    [No Abstract]   [Full Text] [Related]  

  • 17. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
    Sane R; Baribeault D; Rosenberg CL
    Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
    Coppol E; Shelly J; Cheng S; Kaakeh Y; Shepler B
    Ann Pharmacother; 2011 Feb; 45(2):241-7. PubMed ID: 21304025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA; Keating GM
    Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia.
    Friedrisch JR; Cançado RD
    Rev Bras Hematol Hemoter; 2015; 37(6):400-5. PubMed ID: 26670403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.